SANOFICONR share price, P/E, ROE & financials

On 6 Nov 2026, Sanofi Consumer Healthcare India was priced at ₹3,420.20, or 28.2× trailing earnings, against an industry P/E of 37.3×, and the shares are 35% below their 52-week high. It earns ROCE of 77% and ROE of 73%. It has almost no debt, and its dividend yield is 2.2%. It is a small-cap company with a market cap of ₹7,888 Cr, ranked 7th of 15 Drug Manufacturers (General) companies by market cap; the shares fell 29% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year

Open: ₹3,422.00
Day high: ₹3,455.60
Day low: ₹3,369.80
Prev. close: ₹3,443.80
Volume: 6.1K

Health check

3 good · 2 to check

ReturnsBehind
−29.5% over a year, better than 0 of 7 peers.
Price tagCheaper
P/E 28.2 vs industry 37.3.
Growthn/a
Not enough yearly results to measure.
ProfitabilityStrong
ROCE 77.0% vs peer median 23.3%.
Balance sheetSolid
Debt 0.06× equity, interest covered 153.5×.
Red flags1 to check
35% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Drug Manufacturers - General

14 listed peers. Screen the industry

Small cap

₹7,888 Cr, #7 of 15 in its industry by size.

Defensive

Beta 0.34 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹979 Cr · profit ₹280 Cr

Market cap: ₹7,888 Cr; Small cap
P/E: 28.2; Industry 37.3
Price to book: 22.64; Peers 9.15
Dividend yield: 2.19%
ROE: 73.1%; Peers 20.9%
ROCE: 77.0%; Peers 23.3%
Debt to equity: 0.06; Debt ₹21 Cr
EPS (TTM): ₹121.44; Face value ₹10
OPM (TTM): 37.8%; Net margin 28.6%
Sales growth: +12.5%; Latest quarter vs a year ago
Profit growth: +21.8%; Latest quarter vs a year ago
Price to sales: 8.06; EV/EBITDA 20.3

Strengths

Return on equity of 73.1%.
Return on capital employed of 77.0%.
Practically debt-free.
Dividend yield of 2.19%.
Quarterly profit up 21.8% on a year ago.

Risks to check

35% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Sanofi Consumer Healthcare India

Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. The company offers products in the allergy, physical wellness, and pain care segments under Allegra, Combiflam, Avil, DePURA, Festal, and other brand names through distributors, wholesalers, government institutions and hospitals, pharmacy chains, and e-commerce platforms. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi…

Headquarters: Mumbai
Employees: 597
Sector: Healthcare
ISIN: INE0UOS01011
Website: sanofi.com

Price range

52 weeks

₹3,168.20₹5,255.00

Today

₹3,369.80₹3,455.60

Avg volume (3M): 16.4K
1-year return: minus 29.5%
From 52-week high: minus 34.9%

Peers · Drug Manufacturers - General

Compare with peers Screen the whole industry

Company
GLAXOGlaxosmithkline Pharmaceuticals	2,524.80	plus 0.98%	42,772	37.3	22.73	55.4%	63.9%	34.1%	5.7%	19.3%	2.26%	minus 6.0%
RUBICONRubicon Research	1,659.30	minus 4.67%	27,468	95.6	19.38	23.6%	19.1%	23.3%	–	–	0.09%	plus 166.7%
PFIZERPfizer	3,856.00	minus 0.02%	17,640	23.2	4.02	22.9%	20.9%	36.7%	1.3%	5.0%	1.94%	minus 24.6%
CORONACORONA Remedies	2,441.10	plus 2.58%	14,930	72.1	18.55	29.0%	28.3%	21.3%	16.6%	29.7%	0.41%	plus 69.7%
MARKSANSMarksans Pharma	303.70	minus 3.20%	13,764	24.6	4.13	17.5%	15.2%	22.5%	16.7%	16.2%	0.30%	plus 68.0%
SYMBIOTECSymbiotec Pharmalab	1,513.60	plus 19.04%	9,726	103.5	8.26	14.3%	11.2%	10.7%	16.8%	67.3%	0.00%	plus 37.9%
SANOFICONRSanofi Consumer Healthcare India	3,420.20	minus 0.69%	7,888	28.2	22.64	–	80.4%	37.8%	–	–	2.19%	minus 29.5%
SANOFISanofi India	3,283.10	minus 2.75%	7,561	20.7	9.15	–	44.1%	28.0%	–	–	3.75%	minus 28.9%
Median of 7 peers	–	−0.02%	14,930	37.3	9.15	23.3%	20.9%	23.3%	16.6%	19.3%	0.41%	37.9%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
234	251	229	236	263
149	161	140	146	161
85	89.8	88.8	89.3	102
36.3%	35.8%	38.7%	37.9%	38.7%
3	4.6	5.6	6.3	4.4
0.6	0.5	0.5	0.4	0.3
3.3	3.4	3.2	3.3	3.1
84.1	90.5	90.7	91.9	103
25.2%	26.5%	25.2%	25.1%	25.4%
62.9	66.5	67.8	68.8	76.6
27.31	28.87	29.44	29.87	33.26

Profit & loss

Yearly, ₹ crore

ROE: 73.1%

Net profitSelect a row below to chart it

Dec 2023	Dec 2024	Dec 2025
544	716	878
–	+31.6%	+22.6%
325	446	569
219	271	309
40.2%	37.8%	35.2%
4.1	13	18.4
0.2	4	2.1
1.8	4.5	11.7
−1.8	−28.4	6.6
219	247	320
24.8%	26.7%	25.0%
165	181	240
–	+9.8%	+32.7%
71.60	78.59	104.27

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Dec 2023	Dec 2024	Dec 2025
2	23	23
206	250	361
–	20.3	24.8
138	138	138
345	431	547
2	27.9	35.1
–	0.7	–
–	3.6	3.2
1.6	327	375
342	72.2	134
345	431	547

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Dec 2023	Dec 2024	Dec 2025
−0.4	439	175
–	1.9	7.6
2	−116	−135
1.6	325	47.9
−4	−9.9	−7.6
−4.4	429	167
–	−115	−127

Shareholding pattern

Source: NSE filings

71.3%

promoters

Promoters71.27%
Public28.73%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	71.27%	28.73%	0.00
30 Jun 2026	71.27%	28.73%	0.00
31 Mar 2026	71.27%	28.73%	0.00
31 Dec 2025	71.27%	28.73%	0.00
30 Sep 2025	71.27%	28.73%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you